104 related articles for article (PubMed ID: 1339104)
1. Thymidine kinase activity in familial adenomatous polyposis.
Sakamoto S; Okamoto R
Tohoku J Exp Med; 1992 Oct; 168(2):291-301. PubMed ID: 1339104
[TBL] [Abstract][Full Text] [Related]
2. Effects of carcinogenesis on colonic thymidine kinase activity in familial adenomatous polyposis.
Sakamoto S; Kasahara N; Kudo H; Iwama T
Carcinogenesis; 1992 May; 13(5):873-6. PubMed ID: 1316815
[TBL] [Abstract][Full Text] [Related]
3. Increased activities of thymidine kinase isozymes in human colon polyp and carcinoma.
Sakamoto S; Sagara T; Iwama T; Kawasaki T; Okamoto R
Carcinogenesis; 1985 Jun; 6(6):917-9. PubMed ID: 4006080
[TBL] [Abstract][Full Text] [Related]
4. Increased activity of thymidine kinase isozyme in human colon tumor.
Sakamoto S; Iwama T; Tsukada K; Utsunomiya J; Kawasaki T; Okamoto R
Carcinogenesis; 1984 Feb; 5(2):183-5. PubMed ID: 6697435
[TBL] [Abstract][Full Text] [Related]
5. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
6. [Thymidine kinase isozymes in human colon polyps].
Sagara T; Tsukada K; Iwama T; Mishima Y; Sakamoto S; Okamoto R
Nihon Gan Chiryo Gakkai Shi; 1985 Aug; 20(7):1312-6. PubMed ID: 4078430
[No Abstract] [Full Text] [Related]
7. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
8. Relative activities of thymidylate synthetase and thymidine kinase in 1,2-dimethylhydrazine-induced colon carcinomas in rats.
Sakamoto S; Kuwa K; Tsukada K; Sagara T; Kasahara N; Okamoto R
Carcinogenesis; 1987 Mar; 8(3):405-8. PubMed ID: 3815735
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Khan KN; Masferrer JL; Woerner BM; Soslow R; Koki AT
Scand J Gastroenterol; 2001 Aug; 36(8):865-9. PubMed ID: 11495083
[TBL] [Abstract][Full Text] [Related]
10. [Thymidine kinase and its isozyme activities in human thyroid diseases].
Murakami S
Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):921-30. PubMed ID: 3185476
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
13. Activity of the cytosolic isozyme of thymidine kinase in human primary lung tumors with reference to malignancy.
Yusa T; Yamaguchi Y; Ohwada H; Hayashi Y; Kuroiwa N; Morita T; Asanagi M; Moriyama Y; Fujimura S
Cancer Res; 1988 Sep; 48(17):5001-6. PubMed ID: 3409230
[TBL] [Abstract][Full Text] [Related]
14. Group II phospholipase A2 is not a major modifier of colonic adenomatous polyps in humans.
Minami T; Kanayama S; Tojo H; Akedo I; Matsuzawa Y
J Gastroenterol; 1997 Jun; 32(3):431-2. PubMed ID: 9213262
[No Abstract] [Full Text] [Related]
15. Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?
Hertervig E; Nilsson A; Björk J; Hultkrantz R; Duan RD
Br J Cancer; 1999 Sep; 81(2):232-6. PubMed ID: 10496347
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Schmid K; Nair J; Winde G; Velic I; Bartsch H
Int J Cancer; 2000 Jul; 87(1):1-4. PubMed ID: 10861445
[TBL] [Abstract][Full Text] [Related]
17. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
18. Increased activities of thymidine kinase isozymes in human mammary tumours.
Sakamoto S; Iwama T; Ebuchi M; Tsukada K; Sagara T; Kawasaki T; Murakami S; Kasahara N; Kudo H; Okamoto R
Br J Surg; 1986 Apr; 73(4):272-3. PubMed ID: 3697655
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of familial juvenile polyps expressing cyclooxygenase-2.
Brazowski E; Rozen P; Misonzhnick-Bedny F; Gitstein G
Am J Gastroenterol; 2005 Jan; 100(1):130-8. PubMed ID: 15654792
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.
Subramaniam MM; Chan JY; Soong R; Ito K; Yeoh KG; Wong R; Guenther T; Will O; Chen CL; Kumarasinghe MP; Ito Y; Salto-Tellez M
Am J Gastroenterol; 2009 Feb; 104(2):426-36. PubMed ID: 19174785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
